Leading pharmaceutical brands in the U.S. 2022, by DTC
Among leading pharmaceutical brands in the United States in 2022, Dupixent, by Sanofi and Regeneron, ranked first in terms of direct-to-consumer (DTC) advertising spending, with expenditures of over 490 million U.S. dollars. Rinvoq, from AbbVie, followed, with DTC spending of nearly 426 million dollars.